Paden King, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 10, Room 1B55
- Bethesda, MD 20892
- 240-858-3062
- paden.king@nih.gov
RESEARCH SUMMARY
Dr. King is focused on the development of metal-based anticancer therapeutics. He will be applying his knowledge of inorganic chemistry in the lab to develop novel radiometal chelators and conjugates for cancer therapy.
Areas of Expertise
1) metals chemistry 2) radiochemistry 3) cancer molecular radiotherapy
Paden King, Ph.D.
Publications
Exploring the In Vivo and In Vitro Anticancer Activity of Rhenium Isonitrile Complexes
Endoplasmic reticulum stress: an arising target for metal-based anticancer agents
Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes
Metal complexes as a promising source for new antibiotics
In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex
Biography
Paden King, Ph.D.
Dr. Paden King was born and raised in the small town of Statenville, GA. Upon graduating high school, he proceeded to attend Mercer University, where he received Bachelor’s degrees in Chemistry and English Literature. His interest in medicinal chemistry led him to pursue his Ph.D. in bioinorganic chemistry at Cornell University where he worked in the laboratory of Professor Justin Wilson. While at Cornell, Dr. King focused on the development of metal-based anticancer therapeutics. Dr. King received his Ph.D. from Cornell in 2020 and has now joined Dr. Escorcia’s Lab so that he may apply his knowledge of inorganic chemistry to the development of novel radiometal chelators and conjugates for cancer therapy.